Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
1
|
Guidelines on the use of therapeutic apheresis in clinical practice--evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis.
|
J Clin Apher
|
2010
|
3.47
|
2
|
Valproic acid without intensified antiviral therapy has limited impact on persistent HIV infection of resting CD4+ T cells.
|
AIDS
|
2008
|
2.87
|
3
|
Clopidogrel-associated TTP: an update of pharmacovigilance efforts conducted by independent researchers, pharmaceutical suppliers, and the Food and Drug Administration.
|
Stroke
|
2004
|
1.78
|
4
|
Guidelines on the use of therapeutic apheresis in clinical practice: evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis.
|
J Clin Apher
|
2007
|
1.38
|
5
|
A prospective, double-blind, randomized clinical feasibility trial of controlling the storage age of red blood cells for transfusion in cardiac surgical patients.
|
Transfusion
|
2009
|
1.29
|
6
|
Ticlopidine-, clopidogrel-, and prasugrel-associated thrombotic thrombocytopenic purpura: a 20-year review from the Southern Network on Adverse Reactions (SONAR).
|
Semin Thromb Hemost
|
2012
|
1.06
|
7
|
Ticlopidine- and clopidogrel-associated thrombotic thrombocytopenic purpura (TTP): review of clinical, laboratory, epidemiological, and pharmacovigilance findings (1989-2008).
|
Kidney Int Suppl
|
2009
|
1.00
|
8
|
Two mechanistic pathways for thienopyridine-associated thrombotic thrombocytopenic purpura: a report from the SERF-TTP Research Group and the RADAR Project.
|
J Am Coll Cardiol
|
2007
|
0.97
|
9
|
Impact of transfusion of autologous 7- versus 42-day-old AS-3 red blood cells on tissue oxygenation and the microcirculation in healthy volunteers.
|
Transfusion
|
2012
|
0.92
|
10
|
A clinical prediction tool to estimate the number of units of red blood cells needed in primary elective coronary artery bypass surgery.
|
Transfusion
|
2010
|
0.92
|
11
|
The new approach to assignment of ASFA categories--introduction to the fourth special issue: clinical applications of therapeutic apheresis.
|
J Clin Apher
|
2007
|
0.83
|
12
|
Randomized study of washing 40- to 42-day-stored red blood cells.
|
Transfusion
|
2014
|
0.81
|
13
|
Category IV indications for therapeutic apheresis: ASFA fourth special issue.
|
J Clin Apher
|
2007
|
0.81
|
14
|
Acute hemolysis in a patient with cytomegalovirus pneumonitis treated with intravenous immunoglobulin (IVIG).
|
Biol Blood Marrow Transplant
|
2006
|
0.80
|
15
|
Platelet factor 4/heparin antibodies in blood bank donors.
|
Am J Clin Pathol
|
2010
|
0.79
|
16
|
The relationship of plasma transfusion from female and male donors with outcome after cardiac surgery.
|
J Thorac Cardiovasc Surg
|
2010
|
0.78
|
17
|
Ticlopidine-associated ADAMTS13 activity deficient thrombotic thrombocytopenic purpura in 22 persons in Japan: a report from the Southern Network on Adverse Reactions (SONAR).
|
Br J Haematol
|
2013
|
0.77
|
18
|
Relapse of thrombotic thrombocytopenic purpura: is it a continuum of disease?
|
Semin Thromb Hemost
|
2005
|
0.77
|
19
|
Many, but not all, outcome studies support exclusion of female plasma from the blood supply.
|
Expert Rev Hematol
|
2010
|
0.76
|
20
|
Patterns of platelet response in idiopathic TTP/HUS: frequency of declining platelet counts with plasma exchange and the recognition and significance of a pseudo refractory state.
|
Ther Apher Dial
|
2006
|
0.76
|
21
|
Reduced use of allogeneic platelets through high-yield perioperative autologous plateletpheresis and reinfusion.
|
Transfusion
|
2013
|
0.75
|
22
|
Posttransfusion thrombocytopenia: a cautionary tale of female group AB plasma.
|
Transfusion
|
2013
|
0.75
|
23
|
Update on multi-center clinical trials in the United States.
|
Transfus Apher Sci
|
2007
|
0.75
|
24
|
How we approach an apheresis request for a Category III, Category IV, or noncategorized indication.
|
Transfusion
|
2007
|
0.75
|